BioSpace News Archive

Ichnos Sciences Inc. today announced the promotion of Dean Thomas to the position of General Counsel, effective immediately.

Neurodon announced today that it has been awarded approximately $2.9 million in continued funding under its Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA) of the National Institutes of Health (NIH).

Loci Orthopaedics announced today that it has successfully completed enrolment of a 15-patient clinical feasibility study for its patented InDx Implant System.

Neuronetics, Inc., a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help with the best neurohealth therapies in the world, announced that it has drawn down the remaining $22.5 million from its credit facility with SLR Capital Partners, LLC.

Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”), today announced presentation of additional AL Amyloidosis clinical data from its Phase 1b/2a NEXICART-1 (NCT04720313) study of novel, autologous, BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy, NXC-201, at an oral presentation at the 20th International Myeloma Society Annual (IMS) Meeting being held in Athens, Greece on September 27-30 2023.

PAX, a leading global cannabis brand, today announced a collaboration with pioneering Canadian neurotechnology company, Zentrela, leveraging brainwave research to provide consumers with data-driven insight into cannabis effects — ultimately supporting more informed purchasing and consumption decisions.

EQUASHIELD®, a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, is thrilled to announce that its EQUASHIELD® Syringe Unit has received FDA clearance for full-volume use:

Increasing diversity in clinical trials plays a crucial role in helping to understand how a broad range of human bodies may respond to treatments.

Almaden Genomics has added pre-built workflows for single-cell RNA-seq analysis to its g.nome™ platform, enabling understanding of cellular diversity and disease mechanisms

The Association for Diagnostics & Laboratory Medicine is pleased to announce that Maritel Dasco assumed the position of chief financial officer for the association on September 25.